Article
ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell…
OncoTargets and Therapy · 2020 · Kaiho T, Nakajima T, Iwasawa S, Yonemori Y, Yoshino I
Key facts
| Title | ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib |
|---|---|
| First author | Kaiho T, Nakajima T, Iwasawa S, Yonemori Y, Yoshino I |
| Journal | OncoTargets and Therapy |
| Published | Feb 19, 2020 |
| DOI | 10.2147/OTT.S236706 |
| Devices mentioned | K191394, K771219, K912240 |
| Product codes mentioned | BTS, BYE, EOQ, JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1